Literature DB >> 15076932

Mutations in the gyrA and parC genes and in vitro activities of fluoroquinolones in 91 clinical isolates of Neisseria gonorrhoeae in Japan.

Katsumi Shigemura1, Toshiro Shirakawa, Hiroshi Okada, Nobuyuki Hinata, Bishnu Acharya, Shohiro Kinoshita, Tomomi Kofuku, Masato Kawabata, Sadao Kamidono, Soichi Arakawa, Akinobu Gotoh.   

Abstract

BACKGROUND AND OBJECTIVES: Fluoroquinolone resistance in Neisseria gonorrhoeae has been associated with alternations in the quinolone-resistance determining regions in the gyrA and parC genes. GOAL: The goal of this study was to investigate the correlation between fluoroquinolone minimum inhibitory concentrations (MICs) and mutations in the gyrA and parC genes of 91 N. gonorrhoeae clinical isolates from Japan. STUDY
DESIGN: The MICs of fluoroquinolones ciprofloxacin, levofloxacin, and gatifloxacin for 91 clinical isolates from male gonococcal urethritis in Hyogo or Osaka, Japan, were measured, and the gyrA and parC genes of these isolates were sequenced.
RESULTS: Among 91 isolates tested, over 70% isolates were resistant to ciprofloxacin. We found that 4 mutations (Ser-91-Phe, Ser-91-Ile, Asp-95-Gly in gyrA, and Ser-88-Pro in parC) had significant correlation to MICs of fluoroquinolone (ciprofloxacin, levofloxacin, and gatifloxacin).
CONCLUSION: Some mutations in QRDR had a significant relationship to the fluoroquinolone resistance of N. gonorrhoeae clinical isolates from Japan.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15076932     DOI: 10.1097/01.olq.0000114654.91972.66

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  4 in total

1.  In vitro assessment of the further potential for development of fluoroquinolone resistance in Neisseria meningitidis.

Authors:  Tiffany R Shultz; Peter A White; John W Tapsall
Journal:  Antimicrob Agents Chemother       Date:  2005-05       Impact factor: 5.191

2.  Antibiograms and randomly amplified polymorphic DNA-polymerase chain reactions (RAPD-PCR) as epidemiological markers of gonorrhea.

Authors:  Ratana Lawung; Angkana Charoenwatanachokchai; Rungrot Cherdtrakulkiat; Sivarak Thammapiwan; Tharinda Mungniponpan; Leif Bülow; Virapong Prachayasittikul
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

Review 3.  The use of cephalosporins for gonorrhea: the impending problem of resistance.

Authors:  Pennan M Barry; Jeffrey D Klausner
Journal:  Expert Opin Pharmacother       Date:  2009-03       Impact factor: 3.889

4.  Fluoroquinolone resistance and mutation patterns in gyrA and parC genes in Neisseria gonorrhoeae isolates from Shanghai, China.

Authors:  Tiejun Zhang; Xiaoming Zhou; Yue Chen; Weiming Gu; Tao Zhang; Qingwu Jiang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-02-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.